Skip to main content

Table 3 Prognostic ability of each staging system

From: The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma

Patients

linear trend χ2 test

−2 log likelihood

P-value

All patients (n = 150)

   

GPS

53.761

588.797

<0.0001

mGPS

46.707

601.175

<0.0001

CLIP

109.309

545.36

<0.0001

JIS

64.461

570.82

<0.0001

BCLC

61.89

577.75

<0.0001

TNM

41.6

589.84

<0.0001

Curative treatment group (n = 77)

   

GPS

16.33

169.300

<0.0001

mGPS

5.07

177.93

0.03

CLIP

11.28

171.76

0

JIS

9.68

172.22

0

BCLC

N/O

N/O

0.08

TNM

N/O

N/O

0.09

Non-curative treatment group (n = 73)

   

GPS

23.71

322.27

<0.0001

mGPS

28.815

322.579

<0.0001

CLIP

29.480

311.68

<0.0001

JIS

16.72

326.370

<0.0001

BCLC

20.98

321.9

<0.0001

TNM

16.42

326.7

<0.0001

  1. Abbreviations: GPS = Glasgow Prognostic Score; mGPS = modified Glasgow Prognostic Score;
  2. CLIP = the Cancer of the Liver Italian Program; JIS = the Japan Integrated Staging score;
  3. BCLC = the Barcelona Clinic Liver Cancer; TNM = tumor nodes metastasis classification; N/O = not obtained.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us